DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,074 filers reported holding DANAHER CORPORATION in Q4 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,797,485 | +0.4% | 7,245 | -2.9% | 1.93% | +31.9% |
| Q2 2023 | $1,791,120 | -7.4% | 7,463 | -2.8% | 1.46% | +8.5% |
| Q1 2023 | $1,935,163 | +0.9% | 7,678 | +6.2% | 1.35% | -39.9% |
| Q4 2022 | $1,918,456 | -99.9% | 7,228 | +14.2% | 2.24% | +7.0% |
| Q3 2022 | $1,635,492,000 | +56432.7% | 6,332 | -44.5% | 2.10% | +5.3% |
| Q2 2022 | $2,893,000 | -10.3% | 11,410 | +3.8% | 1.99% | +10.1% |
| Q1 2022 | $3,225,000 | -4.1% | 10,994 | +7.5% | 1.81% | +4.1% |
| Q4 2021 | $3,364,000 | +7.2% | 10,225 | -0.8% | 1.74% | -10.5% |
| Q3 2021 | $3,137,000 | +15.1% | 10,305 | +1.5% | 1.94% | +26.9% |
| Q2 2021 | $2,725,000 | -0.4% | 10,155 | -16.5% | 1.53% | -5.3% |
| Q1 2021 | $2,736,000 | -2.6% | 12,155 | -3.9% | 1.61% | -8.2% |
| Q4 2020 | $2,809,000 | -32.7% | 12,645 | -34.8% | 1.76% | -35.7% |
| Q3 2020 | $4,173,000 | +11.8% | 19,380 | -8.2% | 2.74% | +8.8% |
| Q2 2020 | $3,731,000 | +11.8% | 21,100 | -12.4% | 2.51% | +34.9% |
| Q1 2020 | $3,336,000 | -24.5% | 24,100 | -16.3% | 1.86% | +11.7% |
| Q4 2019 | $4,419,000 | +7.1% | 28,790 | +0.8% | 1.67% | -8.0% |
| Q3 2019 | $4,126,000 | -2.1% | 28,570 | -3.1% | 1.81% | -2.2% |
| Q2 2019 | $4,215,000 | +5.0% | 29,490 | -3.0% | 1.85% | +5.3% |
| Q1 2019 | $4,014,000 | +12.4% | 30,405 | -12.2% | 1.76% | +23.3% |
| Q4 2018 | $3,571,000 | -4.2% | 34,627 | +0.9% | 1.43% | +22.7% |
| Q3 2018 | $3,728,000 | +41.3% | 34,312 | +28.4% | 1.16% | +29.1% |
| Q2 2018 | $2,638,000 | +0.3% | 26,732 | -0.5% | 0.90% | -3.6% |
| Q1 2018 | $2,631,000 | +6.6% | 26,875 | +1.1% | 0.94% | +29.0% |
| Q4 2017 | $2,467,000 | -35.1% | 26,575 | -40.1% | 0.72% | -36.2% |
| Q3 2017 | $3,804,000 | +22.4% | 44,345 | +20.4% | 1.14% | +15.8% |
| Q2 2017 | $3,108,000 | -21.4% | 36,825 | -20.3% | 0.98% | -15.9% |
| Q1 2017 | $3,954,000 | +8.9% | 46,225 | -0.9% | 1.17% | -4.3% |
| Q4 2016 | $3,632,000 | -0.7% | 46,655 | 0.0% | 1.22% | +0.7% |
| Q3 2016 | $3,657,000 | -9.2% | 46,655 | +17.0% | 1.21% | -21.8% |
| Q2 2016 | $4,028,000 | -8.6% | 39,885 | -14.2% | 1.55% | -3.2% |
| Q1 2016 | $4,407,000 | -0.3% | 46,460 | -2.4% | 1.60% | +3.5% |
| Q4 2015 | $4,419,000 | +9.7% | 47,580 | +0.6% | 1.55% | +6.5% |
| Q3 2015 | $4,029,000 | +55.4% | 47,280 | +56.1% | 1.45% | +67.4% |
| Q2 2015 | $2,592,000 | +1.8% | 30,280 | +1.0% | 0.87% | -10.8% |
| Q1 2015 | $2,545,000 | +0.4% | 29,980 | +1.4% | 0.97% | -0.4% |
| Q4 2014 | $2,535,000 | +3.5% | 29,580 | -8.3% | 0.98% | +1.0% |
| Q3 2014 | $2,450,000 | -2.9% | 32,250 | +0.6% | 0.97% | -2.4% |
| Q2 2014 | $2,523,000 | +2.9% | 32,050 | -1.9% | 0.99% | -1.1% |
| Q1 2014 | $2,451,000 | +3.9% | 32,675 | +6.9% | 1.00% | +1.4% |
| Q4 2013 | $2,360,000 | – | 30,575 | – | 0.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |